CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia

被引：0
作者：
Na Yang
Caili Zhang
Yingchun Zhang
Yuting Fan
Jing Zhang
Xiaojin Lin
Ting Guo
Yangzuo Gu
Jieheng Wu
Jianmei Gao
Xing Zhao
Zhixu He
机构：
[1] Guizhou Medical University (GMU),Tissue Engineering and Stem Cell Experiment Center
[2] Guizhou Medical University,Department of Immunology, College of Basic Medical Sciences
[3] Guizhou Medical University,Department of Biology, School of Basic Medical Sciences
[4] the Affiliated Hospital of Guizhou Medical University,Department of Gynecology
[5] Sichuan University,State Key Laboratory of Biotherapy and Cancer Center
[6] Zunyi Medical University,School of Pharmacy
[7] Chinese Academy of Medical Sciences),Key Laboratory of Adult Stem Cell Translational Research
[8] the Affiliated Hospital of Zunyi Medical University,Department of Pediatrics
来源：
Journal of Translational Medicine | / 22卷
关键词：
Chimeric antigen receptor; Natural killer cells; Dual targets; mRNA; Acute lymphoblastic leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 45 条
  • [31] CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN- Production Profile
    Magalhaes, Isabelle
    Kalland, Ingrid
    Kochenderfer, James N.
    Osterborg, Anders
    Uhlin, Michael
    Mattsson, Jonas
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (02) : 73 - 83
  • [32] Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy
    Tambaro, Francesco Paolo
    Khazal, Sajad
    Nunez, Cesar
    Ragoonanan, Dristhi
    Tewari, Priti
    Petropoulos, Demetrios
    Kebriaei, Partow
    Wierda, William George
    Mahadeo, Kris Michael
    CLINICAL CASE REPORTS, 2020, 8 (09): : 1678 - 1681
  • [33] Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia
    Wang, Xiangmin
    Zhang, Bingpei
    Zhang, Qing
    Zhou, Hongyuan
    Sun, Qian
    Zhou, Yi
    Li, Tianci
    Zhou, Dian
    Shen, Ziyuan
    Zhang, Jiaoli
    Li, Ping
    Liang, Aibin
    Zhou, Keshu
    Han, Lu
    Hu, Yongxian
    Yang, Yun
    Cao, Jiang
    Li, Zhenyu
    Xu, Kailin
    Sang, Wei
    CANCER, 2024, 130 (15) : 2660 - 2669
  • [34] Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells
    Klaihmon, Phatchanat
    Kang, Xing
    Issaragrisil, Surapol
    Luanpitpong, Sudjit
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [35] Anti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia Two case reports
    Zhu, Yang-min
    Wu, Zhao
    Tan, You-ping
    Du, Yuan-yuan
    Liu, Zhi
    Ou, Rui-ming
    Liu, Shuang
    Pu, Cheng-fei
    Jiang, Jing
    Wang, Jin-ping
    Xiao, Lei
    Zhang, Qing
    MEDICINE, 2016, 95 (51) : e5676
  • [36] Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients
    Wang, Ying
    Li, Hujun
    Song, Xuguang
    Qi, Kunming
    Cheng, Hai
    Cao, Jiang
    Shi, Ming
    Yan, Zhiling
    Jing, Guangjun
    Pan, Bin
    Sang, Wei
    Wang, Xiangmin
    Zhao, Kai
    Chen, Chong
    Chen, Wei
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (02) : 250 - 258
  • [37] Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
    Chu, Yaya
    Yahr, Ashlin
    Huang, Brian
    Ayello, Janet
    Barth, Matthew
    Cairo, Mitchell S.
    ONCOIMMUNOLOGY, 2017, 6 (09):
  • [38] Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    Chen, Yu-Hong
    Zhang, Xian
    Cheng, Yi-Fei
    Chen, Huan
    Mo, Xiao-Dong
    Yan, Chen-Hua
    Chen, Yao
    Han, Wei
    Sun, Yu-Qian
    Wang, Yu
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Liu, Kai-Yan
    Yang, Junfang
    Zhang, Jianping
    Zhang, Gai-Ling
    Shi, Yanze
    Su, Yun-Chao
    Li, Wen-Qian
    Xu, Li
    Song, Dan
    Zhang, Min
    Lu, Peihua
    Huang, Xiao-Jun
    CYTOTHERAPY, 2020, 22 (12) : 755 - 761
  • [39] Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms
    Wu, Sungui
    Luo, Qian
    Li, Feiyu
    Zhang, Suwen
    Zhang, Cuiling
    Liu, Jianwei
    Shao, Bang
    Hong, Yang
    Tan, Taochao
    Dong, Xiaoqing
    Chen, Bing
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1361 - 1373
  • [40] CD19 chimeric antigen receptor-redirected T cells combined with epidermal growth factor receptor pathway substrate 8 peptide-derived dendritic cell vaccine in leukemia
    Wu, Meirong
    Zhang, Litian
    Zhang, Hanzhen
    Ning, Jingxuan
    Tu, Sanfang
    He, Yanjie
    Li, Yuhua
    CYTOTHERAPY, 2019, 21 (06) : 659 - 670
12345